Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
about
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistanceExpression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal statusProstate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?Reconnoitring the status of prostate specific antigen and its role in womenEmerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesThe emerging roles of human tissue kallikreins in cancerElevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease.The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.Role of axillary surgery in early breast cancer: review of the current evidence.The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.The expression of prostate-specific antigen in invasive breast carcinoma and its relationship with routine clinicopathologic parameters.Predictive and prognostic markers for invasive breast cancer.Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3.Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women.Immunohistochemical analysis of prostate specific antigen in breast cancer.The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology
P2860
Q24642804-6B0D590E-2F13-4312-B868-6AEC8A94D5FFQ24652262-93E8F75C-33FC-4705-8E2C-A428A1768B20Q24801573-2DC6067D-0848-4992-8741-FAD0D6DB5DC7Q26995569-D8B18D44-A56F-4ECD-9777-503ABD248140Q27007065-89D1C090-2D93-4039-BBC3-625E3A32FD88Q28290701-FA8F9AC2-EA80-420A-9983-B62A1E34518BQ33186595-5A70810F-2363-4C7D-808E-8C59CD7BB43CQ33884420-DA3CEA4F-1D84-4B1C-873C-BD53571D848EQ33972653-7E539CA5-5013-48E0-B5BE-52F0BCBC2CC4Q34447102-63E78249-E3FF-42C6-AE6F-C74C7FAF3592Q34552414-6FC62233-BE93-41DA-9505-98347E508A80Q34612314-E3E7D0E8-024D-4B92-B978-0010C0CADEA7Q36936018-2431E2D5-4701-4ABC-B4E1-B8C1D13DEF8AQ37714914-F8414EF0-5201-4949-A2C7-012E321D0621Q40025080-BED872B3-4E88-4B9A-9ED0-9D199F699A5CQ40717386-1567D73F-16EA-4262-9500-7DEE71ED294EQ41208085-2AEFDE29-5F5E-4F2A-8A23-7E4A340CA462Q43785975-09DA65FE-8C54-44A5-8F76-3EB35DD23789Q58707374-1D8F50D8-6AFF-49D1-8FBB-A7E34B05032F
P2860
Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Expression of prostate-specifi ...... apy in recurrent breast cancer
@ast
Expression of prostate-specifi ...... apy in recurrent breast cancer
@en
type
label
Expression of prostate-specifi ...... apy in recurrent breast cancer
@ast
Expression of prostate-specifi ...... apy in recurrent breast cancer
@en
prefLabel
Expression of prostate-specifi ...... apy in recurrent breast cancer
@ast
Expression of prostate-specifi ...... apy in recurrent breast cancer
@en
P2093
P2860
P356
P1476
Expression of prostate-specifi ...... apy in recurrent breast cancer
@en
P2093
Diamandis EP
Foekens JA
Meijer-van Gelder ME
van Putten WL
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690142
P407
P577
1999-02-01T00:00:00Z
P5875
P6179
1018578853